The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2021 to 2030.Intravenous infusion pump is a medical device used to infuse medications or nutrients into a patient’s circulatory system. These are commonly found in a medical settings, as they are widely used in transferring medications in accurate dosages.
The key factors that drive the growth of the global intravenous infusion pump market are increase in geriatric population and rise in prevalence of chronic diseases. In addition, surge in adoption of portable infusion pumps to reduce hospital expenditure is expected to supplement the growth. However, patient safety risks and medication errors related to infusion pumps restrict the intravenous infusion pump market growth. Conversely, technological advancements in infusion pumps are expected to create lucrative opportunities for key market players during the forecast period.
Infusion pumps such as ambulatory chemotherapy pumps, implantable pumps, and insulin pumps are useful for managing various diseases, such as cancer and diabetes, in home care settings. Furthermore, ambulatory infusion pumps are designed to be portable or wearable. In addition, infusion pumps are used to deliver fluids such as nutrients, medicines, and antibiotics in a patient’s body precisely and under a controlled environment. They are commonly used in hospitals, ambulatory surgery centers, home settings, infusion clinics, and long-term care facilities. In the last few years, the demand for home healthcare has increased significantly, owing to high prevalence of chronic diseases and rise in healthcare expenditure, majorly on hospitalization. Home healthcare provides patients with an affordable option compared to expensive hospital care, which, in turn, helps reduce the public expenditure on healthcare services. With the increasing need to reduce hospital stays, patients are increasingly adopting ambulatory infusion pumps that are cheaper than most other infusion pumps as well as easier to use. Thus, all these factors collectively boost the demand for infusion pump products, thereby augmenting the intravenous infusion pump market growth.
Infusion pumps and ventilators can be considered critical devices, as these devices are used in ICUs, CCUs, and emergency departments. IV infusion is a common need in COVID wards. Infusion pumps are used in hospitals and other emergency centers to control and deliver doses of medication, and because they can be set to do this without constant supervision, they allow doctors and nurses to treat patients with minimal exposure to infection. Hence, the demand for infusion pumps grew significantly in 2020. This made the supply and distribution of infusion pumps a major challenge.
Owing to increase in spending on long-term care, the preference for homecare settings has been rising substantially. Ambulatory infusion pumps in homecare settings are more in demand due to rise in expenditure majorly on hospitalization and increase in prevalence of chronic diseases. Increase in the rate of adopting ambulatory infusion pumps and rise in need to reduce hospital stays are critical factors for surge in demand for ambulatory infusion pumps in homecare settings.
Intrvenous Infusion Pump Market Segmentation
The global Intravenous infusion pump market is segmented into type, application, end user and region. By type, the market is categorized into volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps. The applications covered in the study include oncology, parenteral nutrition, analgesia/pain management, and others. On the basis of end user, the market is segregated into hospitals & clinics, home healthcare, and others.
By Type
Volumetric Infusion Pumps segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment review
Depending on type, the volumetric infusion pumps segment was the major revenue contributor in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in adoption of technologically advanced volumetric infusion pumps that exhibit the capabilities such as electronic health record (EHR) integration, built-in safety systems, as well as drug library, which is a list of drugs stored in the smart pump’s memory, serving as a key tool to prevent medication errors. Moreover, as the socio-economic prospect of developing countries is improving, more people are expected to be able to opt for the use of volumetric pumps in home healthcare, which is the key driving factor of the volumetric infusion pump segment. On the basis of application, the oncology segment led the market in 2020, and is anticipated to maintain its lead during the forecast period. This is attributed to rise in prevalence of cancer, as these pumps are extensively used to administer drugs during treatment of these diseases.
By Application
Oncology segment is projected as one of the most lucrative segments.
On the basis of end user, the hospitals & clinics segment led the market in 2020, and is anticipated to maintain its lead during the forecast period. This is attributed to the availability of smart and advanced intravenous infusion pumps in hospitals along with high prevalence of chronic diseases and rise in healthcare expenditure.
By End User
Hospitals & Clinics segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.
North America was the largest shareholder in the global intravenous infusion pump market in 2020, owing to its well-established healthcare infrastructure, favorable reimbursement, high chronic disease burden, advancements in infusion technology, and supportive government regulations for product commercialization. However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period, owing to alarming rise in burden of chronic diseases such as cancer & diabetes, surge in number of surgical procedures performed, rapid adoption of innovative medical devices, and the regional presence of major global players.
By Regio
Asia-Pacific region would exhibit the highest CAGR of 9.30% during 2021-2030
Some of the major companies that operate in the global intravenous infusion pump market are F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU Medical, Inc., and Tandem Diabetes Care, Inc.
Key Benefits For Stakeholders
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global intravenous infusion pump market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global intravenous infusion pump market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the intravenous infusion pump market trends and dynamics
Key Market Segments
By Type
- Volumetric Infusion Pumps
- Syringe Infusion Pumps
- Patient Controlled Analgesia Infusion Pumps
By Application
- Oncology
- Parenteral Nutrition
- Analgesia/Pain Management
- Others
By End User
- Hospitals & Clinics
- Home Healthcare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- B. Braun Holding GmbH & Co. KG
- Becton, Dickinson and Company
- Baxter International, Inc.
- Terumo Corporation
- Medtronic
- Smith Medical
- ICU Medical, Inc.
- Tandem Diabetes Care, Inc.
Intravenous Infusion Pump Market Report Highlights
| Aspects | Details |
 By TYPE |
|
 By APPLICATION |
|
 By END USER |
|
 By Region |
|
 Key Market Players | Terumo Corporation, F. Hoffmann-La Roche Ltd., Medtronic, Becton, Dickinson and Company, Fresenius SE & Co. KGaA, Tandem Diabetes Care, Inc., ICU Medical, Inc., Baxter International, Inc., B. Braun Holding GmbH & Co. KG, Smith Medical |
Analyst Review
The intravenous infusion pump market gained prominence in 2020, and is expected to witness a significant rise in the near future. This is attributed to increase in prevalence of chronic diseases & disorders, continuous product commercialization, market availability & product affordability, and rise in public awareness related to preventive care. However, lack of reimbursement policy is expected to hamper the market growth.
The intravenous infusion pump market has piqued the interest of healthcare providers, owing to numerous benefits offered by these devices to treat several clinical disorders. There have been remarkable technological advancements to provide advanced treatment options for the management of cardiovascular diseases. As the market is saturated with steady growth rate in developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to the key players.
Other key factors likely to drive the demand for these products are rise in prevalence of cancer and rapid increase in the aging population globally. In addition, upsurge in adoption of portable infusion pumps and improvement of healthcare infrastructure in emerging countries supplement the market growth.
The total market value of intravenous infusion pump marketis $4,154.30 million in 2020.
The forcast period for intravenous infusion pump marketis 2021 to 2030
The market value of intravenous infusion pump marketin 2030 is $8,147.20 million.
The base year is 2020 in intravenous infusion pump market
Top companies such as,Acadia Healthcare, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU MEDICAL, INC., Tandem Diabetes Care, Inc held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
By type volumetric infusion pumps segment is the most influencing segment. The growing trend of adoption of technologically advanced volumetric infusion pumps that possess capabilities such as EHR integration, build-in safety systems as well as drug libraries and others. Moreover, as the socio-economic prospect of developing countries improving, more people are expected to be able to opt for the use of volumetric pumps in home healthcare are the key driving factors in the volumetric infusion pump segment.
The major factor that fuels the growth of the global intravenous infusion pump market includes, Increasing prevalence of chronic diseases and rising demand for ambulatory infusion pumps in home care settings, Technological advancements leading to products with improved features, Rising demand for ambulatory infusion pumps in homecare settings drive the growth of the global Intravenous infusion pump market. However, product recalls is expected to hamper the market growth.
Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to to increase in health awareness, development in health care infrastructure, and rise in the number of hospitals equipped with advanced medical facilities.
An infusion pump is a medical device that delivers fluids, such as nutrients and medications, into a patient’s body in controlled amounts. Infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in the home
oncology, parenteral nutrition, analgesia/pain management and others
Loading Table Of Content...
